Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Philip Maes, Anthony K.C. Chan et al.|The Lancet Haematology|2019Cited by 329
Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assayBettina Schenk, Mirjam Bachler, Philipp Würtinger et al.|British Journal of Anaesthesia|2016Cited by 29
Epidemiology and Treatment of Patients with Haemophilia in Austria—Update from the Austrian Haemophilia RegistryJudit Rejtő, Ingrid Pabinger, Sylvia Reitter-Pfoertner et al.|Hämostaseologie|2018Cited by 7
Sixteen Years of Treatment with Pasteurized Human Clotting Factor Concentrates in Children and Adolescents: A Pharmacosurveillance Investigation Comprising 727 Patient YearsW. Muntean, Karl Zwiauer, Werner Zenz et al.|Seminars in Thrombosis and Hemostasis|2002Cited by 5
Hämophilie-Behandlung in ÖsterreichChristoph Male, Ingrid Pabinger, Cihan Ay et al.|Wiener klinische Wochenschrift|2024Cited by 4